Literature DB >> 4656603

Species and ionic influences on the accumulation of digitalis glycosides by isolated perfused hearts.

S Dutta, B H Marks.   

Abstract

1. The ability of isolated perfused guinea-pig (digitalis-sensitive species) and rat (digitalis-resistant species) hearts to accumulate radio-labelled digitalis glycosides was studied in relation to the ionic composition of the perfusion medium.2. It was observed that in both species much less digoxin was accumulated than was digitoxin or proscillaridin.3. The accumulation of digoxin was markedly inhibited in a low sodium or in high potassium medium. These effects were similar, but relatively less marked, with digitoxin and proscillaridin. Calcium and magnesium removal had relatively smaller effects on the accumulation of both polar and non-polar glycosides.4. The low accumulation of all digitaloids by the rat heart in comparison to the guinea-pig heart may be due to the formation of unstable complexes between the cellular membranes in the rat heart and the various digitaloids used in this study. Although digitaloids have a reduced affinity for rat hearts and rat heart membranes in comparison to guinea-pigs, the order of the accumulation of different glycosides in both species is the same, i.e. much less with polar glycosides than with non-polar glycosides.5. It was concluded that non-polar glycosides such as digitoxin and proscillaridin demonstrate the same ion-dependent accumulation mechanism as do the more polar glycosides such as digoxin and ouabain. In addition, the non-polar glycosides possess high capacity for ion-independent binding presumably due to lipophilic interactions with membranes.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4656603      PMCID: PMC1666495          DOI: 10.1111/j.1476-5381.1972.tb08137.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  The uptake and binding of six radiolabeled cardiac glycosides by guinea-pig hearts and by isolated sarcoplasmic reticulum.

Authors:  S Dutta; S Goswami; D K Datta; J O Lindower; B H Marks
Journal:  J Pharmacol Exp Ther       Date:  1968-11       Impact factor: 4.030

2.  Studies on the interaction of ouabain and other cardio-active steroids with sodium-potassium-activated adenosine triphosphatase.

Authors:  R W Albers; G J Koval
Journal:  Mol Pharmacol       Date:  1968-07       Impact factor: 4.436

3.  A possible biochemical explanation for the insensitivity of the rat to cardiac glycosides.

Authors:  J C Allen; A Schwartz
Journal:  J Pharmacol Exp Ther       Date:  1969-07       Impact factor: 4.030

4.  Factors that regulate ouabain-H3 accumulation by the isolated guinea-pig heart.

Authors:  S Dutta; B H Marks
Journal:  J Pharmacol Exp Ther       Date:  1969-12       Impact factor: 4.030

5.  Sodium dependence of the rate of onset of the ouabain-induced positive inotropic effect on cardiac muscle.

Authors:  M S Talbot
Journal:  Nature       Date:  1968-09-07       Impact factor: 49.962

6.  The effects of six cardiac glycosides on the transmembrane potential and contractile characteristics of the right ventricle of guinea pigs.

Authors:  M Ito; P B Hollander; B H Marks; S Dutta
Journal:  J Pharmacol Exp Ther       Date:  1970-03       Impact factor: 4.030

7.  Potassium ions and the binding of cardiac glycosides to mammalian cells.

Authors:  P F Baker; J S Willis
Journal:  Nature       Date:  1970-05-09       Impact factor: 49.962

8.  The effect of the ionic milieu on the response of rabbit cardiac muscle to ouabain.

Authors:  A Caprio; A Farah
Journal:  J Pharmacol Exp Ther       Date:  1967-03       Impact factor: 4.030

9.  Modification by sodium and calcium of the cardiotoxicity induced by ouabain.

Authors:  N Toda; T C West
Journal:  J Pharmacol Exp Ther       Date:  1966-11       Impact factor: 4.030

10.  A comparison of the accumulation and release of 3H-ouabain and 3H-digitoxin by guinea-pig heart muscle.

Authors:  K Kuschinsky; H Lüllmann; P A van Zwieten
Journal:  Br J Pharmacol Chemother       Date:  1968-03
  10 in total
  8 in total

1.  Inotropic action, myocardial uptake and subcellular distribution of ouabain, digoxin and digitoxin in isolated rat hearts.

Authors:  U Fricke; U Hollborn; W Klaus
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Reduction of the equilibrium binding of cardiac glycosides and related compounds to Na+,K+-ATPase as a possible mechanism for the potassium-induced reversal of their toxicity.

Authors:  T Akera; K Temma; S A Wiest; T M Brody
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-09       Impact factor: 3.000

3.  Bilary and urinary excretion of five cardiac glycosides and its correlation with their physical and chemical properties.

Authors:  A Marzo; P Ghirardi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-05       Impact factor: 3.000

4.  Beta-methyl-digoxin. V. Protein binding, tissue distribution and extra-cardiac effects in rats and mice.

Authors:  A Roesch; K Koch; W Schaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Ouabain: temporal relationship between the inotropic effect and the in vitro binding to, and dissociation from, (Na + + K + )- activated ATPase.

Authors:  T Akera; S I Baskin; T Tobin; T M Brody
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

6.  The uptake and subcellular distribution of radio-labelled metabolites of digitoxin in the guinea-pig isolated perfused heart.

Authors:  S Dutta; B H Marks; P M Stephen
Journal:  Br J Pharmacol       Date:  1976-04       Impact factor: 8.739

7.  Investigation of cardiac glycoside levels in human post mortem blood and tissues determined by a special radioimmunoassay procedure.

Authors:  R Aderjan; H Buhr; G Schmidt
Journal:  Arch Toxicol       Date:  1979-06-08       Impact factor: 5.153

8.  Relationship between dose and plasma level of digoxin and patient characteristics.

Authors:  N Heinz; N Rietbrock
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.